JiangXi Tianxin Pharmaceutical Co., Ltd. (SHA:603235)
China · Delayed Price · Currency is CNY 27.09
-0.11 (-0.40%)
At close: Jan 22, 2026
SHA:603235 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
Net Income | 617.04 | 651.22 | 475.85 | 622.12 | 743.89 | 887.09 | Upgrade |
Depreciation & Amortization | 153.93 | 153.93 | 138.75 | 127.11 | 110.13 | 89.33 | Upgrade |
Other Amortization | 1.62 | 1.62 | 1.39 | 2.04 | 5.95 | 8.2 | Upgrade |
Loss (Gain) From Sale of Assets | -0 | -0 | - | - | 3.33 | 3.24 | Upgrade |
Asset Writedown & Restructuring Costs | 8.62 | 8.62 | 12.45 | 0.9 | 4.89 | 0.53 | Upgrade |
Loss (Gain) From Sale of Investments | -7.68 | -7.68 | -2.07 | -6.63 | 2.28 | -8.43 | Upgrade |
Provision & Write-off of Bad Debts | 3.46 | 3.46 | -3.16 | -3.23 | 7.03 | -1.05 | Upgrade |
Other Operating Activities | 35.65 | -49.22 | -25.67 | -56.45 | 32.65 | 81.52 | Upgrade |
Change in Accounts Receivable | -239.11 | -239.11 | 7.15 | 63.92 | -167.58 | 8.61 | Upgrade |
Change in Inventory | -117.2 | -117.2 | -20.51 | -68.39 | -75.7 | -63.81 | Upgrade |
Change in Accounts Payable | 128.49 | 128.49 | 82.92 | -51.3 | 62.92 | 60.55 | Upgrade |
Change in Other Net Operating Assets | -32.42 | -32.42 | 84.63 | -26.34 | 107.86 | 116.44 | Upgrade |
Operating Cash Flow | 550.35 | 499.66 | 729.21 | 606.61 | 818.63 | 1,164 | Upgrade |
Operating Cash Flow Growth | -5.78% | -31.48% | 20.21% | -25.90% | -29.65% | 19.94% | Upgrade |
Capital Expenditures | -785.51 | -1,067 | -535.6 | -260.5 | -215.5 | -303.04 | Upgrade |
Sale of Property, Plant & Equipment | 0.28 | 0.27 | - | - | 7.17 | 0.11 | Upgrade |
Investment in Securities | -479.44 | -479.44 | 230 | -230.5 | - | - | Upgrade |
Other Investing Activities | 452.39 | 5.46 | 2.45 | 35.66 | -31.21 | 5.46 | Upgrade |
Investing Cash Flow | -812.28 | -1,541 | -303.15 | -455.34 | -239.54 | -297.47 | Upgrade |
Long-Term Debt Issued | - | 312.43 | 100 | 90 | 300 | 370 | Upgrade |
Long-Term Debt Repaid | - | -272.42 | -3.17 | -433.71 | -307.49 | -345.19 | Upgrade |
Net Debt Issued (Repaid) | 279.8 | 40.01 | 96.83 | -343.71 | -7.49 | 24.81 | Upgrade |
Issuance of Common Stock | - | - | - | 1,540 | - | - | Upgrade |
Repurchase of Common Stock | -60.01 | -60.01 | - | - | - | - | Upgrade |
Common Dividends Paid | -302.35 | -220.19 | -312.42 | -6.83 | -878.47 | -853.39 | Upgrade |
Other Financing Activities | 70.37 | - | - | -26.6 | - | - | Upgrade |
Financing Cash Flow | -12.19 | -240.19 | -215.59 | 1,162 | -885.96 | -828.58 | Upgrade |
Foreign Exchange Rate Adjustments | 16.8 | 51.71 | 27.77 | 63.37 | -19.98 | -68.46 | Upgrade |
Net Cash Flow | -257.32 | -1,230 | 238.24 | 1,377 | -326.86 | -30.83 | Upgrade |
Free Cash Flow | -235.15 | -567.3 | 193.61 | 346.11 | 603.13 | 860.63 | Upgrade |
Free Cash Flow Growth | - | - | -44.06% | -42.61% | -29.92% | 17.45% | Upgrade |
Free Cash Flow Margin | -10.56% | -25.69% | 10.29% | 15.02% | 23.91% | 37.36% | Upgrade |
Free Cash Flow Per Share | -0.54 | -1.30 | 0.44 | 0.84 | 1.53 | 2.18 | Upgrade |
Cash Income Tax Paid | 126.79 | 130.8 | 55.13 | 125.68 | 114.88 | 189.13 | Upgrade |
Levered Free Cash Flow | -214.08 | -715.82 | -28.07 | 176.18 | -619.31 | 659.47 | Upgrade |
Unlevered Free Cash Flow | -210.85 | -714.27 | -26.76 | 180.51 | -611.39 | 667.63 | Upgrade |
Change in Working Capital | -262.28 | -262.28 | 131.67 | -79.24 | -91.53 | 103.25 | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.